BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 12804130)

  • 1. Hyperglycemia from olanzapine treatment in adolescents.
    Bloch Y; Vardi O; Mendlovic S; Levkovitz Y; Gothelf D; Ratzoni G
    J Child Adolesc Psychopharmacol; 2003; 13(1):97-102. PubMed ID: 12804130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Olanzapine-induced destabilization of diabetes in the absence of weight gain.
    Ramankutty G
    Acta Psychiatr Scand; 2002 Mar; 105(3):235-6; discussion 236-7. PubMed ID: 11939979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperglycemia associated with olanzapine.
    Fertig MK; Brooks VG; Shelton PS; English CW
    J Clin Psychiatry; 1998 Dec; 59(12):687-9. PubMed ID: 9921705
    [No Abstract]   [Full Text] [Related]  

  • 4. Olanzapine-induced glucose dysregulation.
    Bettinger TL; Mendelson SC; Dorson PG; Crismon ML
    Ann Pharmacother; 2000; 34(7-8):865-7. PubMed ID: 10928397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperglycemia and hypertriglyceridemia secondary to olanzapine.
    Domon SE; Webber JC
    J Child Adolesc Psychopharmacol; 2001; 11(3):285-8. PubMed ID: 11642478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ziprasidone alternative for olanzapine-induced hyperglycemia.
    Spivak B; Alamy SS; Jarskog LF; Sheitman BB; Lieberman JA
    Am J Psychiatry; 2002 Sep; 159(9):1606. PubMed ID: 12202289
    [No Abstract]   [Full Text] [Related]  

  • 7. Weight gain and hyperglycaemia associated with olanzapine.
    Riccitelli G; Baker N
    Aust N Z J Psychiatry; 2002 Apr; 36(2):270-1. PubMed ID: 11982558
    [No Abstract]   [Full Text] [Related]  

  • 8. Olanzapine induces remarkable weight gain in adolescent patients.
    Haapasalo-Pesu KM; Saarijärvi S
    Eur Child Adolesc Psychiatry; 2001 Sep; 10(3):205-8. PubMed ID: 11596822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Importance of blood glucose level when starting antipsychotic treatment].
    Dervaux A; Mascarenhas N; Lambolez T
    Presse Med; 2001 Sep; 30(26):1298. PubMed ID: 11603092
    [No Abstract]   [Full Text] [Related]  

  • 10. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term olanzapine treatment: weight change and weight-related health factors in schizophrenia.
    Kinon BJ; Basson BR; Gilmore JA; Tollefson GD
    J Clin Psychiatry; 2001 Feb; 62(2):92-100. PubMed ID: 11247108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperglycemia and olanzapine.
    Ober SK; Hudak R; Rusterholtz A
    Am J Psychiatry; 1999 Jun; 156(6):970. PubMed ID: 10360147
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine-induced mania.
    Reeves RR; McBride WA; Brannon GE
    J Am Osteopath Assoc; 1998 Oct; 98(10):549-50. PubMed ID: 9821737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olanzapine-induced hyperventilation: case report.
    Sattar SP; Gastfriend DR
    J Psychiatry Neurosci; 2002 Sep; 27(5):360-3. PubMed ID: 12271791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperglycemia and ketoacidosis associated with olanzapine].
    Von Hayek D; Hüttl V; Reiss J; Schweiger HD; Füessl HS
    Nervenarzt; 1999 Sep; 70(9):836-7. PubMed ID: 10522253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pilot study of risperidone, olanzapine, and haloperidol in psychotic youth: a double-blind, randomized, 8-week trial.
    Sikich L; Hamer RM; Bashford RA; Sheitman BB; Lieberman JA
    Neuropsychopharmacology; 2004 Jan; 29(1):133-45. PubMed ID: 14583740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esotropia associated with olanzapine.
    Singh HK; Markowitz GD; Myers G
    J Clin Psychopharmacol; 2000 Aug; 20(4):488. PubMed ID: 10917412
    [No Abstract]   [Full Text] [Related]  

  • 18. Olanzapine associated weight gain, hyperglycemia and neuroleptic malignant syndrome: case report.
    Malyuk R; Gibson B; Procyshyn RM; Kang N
    Int J Geriatr Psychiatry; 2002 Apr; 17(4):326-8. PubMed ID: 11994885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine: a new typical antipsychotic drug.
    Meltzer HY; Fibiger HC
    Neuropsychopharmacology; 1996 Feb; 14(2):83-5. PubMed ID: 8822530
    [No Abstract]   [Full Text] [Related]  

  • 20. Olanzapine-lnduced hyperglycemic nonketonic coma.
    Roefaro J; Mukherjee SM
    Ann Pharmacother; 2001 Mar; 35(3):300-2. PubMed ID: 11261526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.